Mount Sinai Hospital scientists receive new funding from the Ontario Ministry of Research and Innovation
(September 15, 2011—Toronto, ON) The research teams of three senior scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital were awarded new funding from the Ontario Ministry of Research and Innovationin the latest provincial Research Fund grants. The announced support will enable Lunenfeld scientists to pursue innovative research toward the development of new therapies for cancer, rheumatoid arthritis as well as other autoimmune disorders.
Almost 90 per cent of the Lunenfeld’s funding is derived from competitive research granting agencies, and Lunenfeld scientists’ success in attracting this funding has consistently exceeded the national performance over the last decade. The Ontario government promotes scientific excellence through its Research Fund competition each year and, through a commitment of $730 million over four years, Ontario is providing talented researchers with the support they need to undertake world class research.
“The Ontario government is a key funder of health research in support of our scientists, and competition for its funds is extremely vigorous,” noted Dr. Jim Woodgett, the Lunenfeld’s Director of Research. “Our investigators were awarded over $11.8 million in this particular competition, which reflects the exceptional caliber of work being conducted here.”
Specifically, the new research operating funds will support the teams of Drs. Tony Pawson, Daniel Durocher and Katherine Siminovitch, for their research into cancer and anti-cancer therapies; the relationships between genes and proteins (particularly those involved in cancer); as well as the genes responsible for two debilitating autoimmune diseases, rheumatoid arthritis and primary biliary cirrhosis.
“The Province of Ontario only invests in the very best research and these awards assure our philanthropic donors that their generosity is well placed,” said Dr. Woodgett. “We can never thank them enough for supporting our vision to achieve the best in health care.”
Facts and figures:
- The Lunenfeld ranks among the top 2.5 per cent of academic research institutes worldwide (www.scimagoir.com).
- Lunenfeld scientists currently hold more than $200 million in grants and awards. In a recent CIHR funding competition (the largest funder of health research in Canada), Lunenfeld scientists attracted double the national average in grants.
- Almost 90 per cent of the Lunenfeld’s funding is derived from competitive research granting agencies including the Canadian Institutes of Health Research, Genome Canada, the Canada Foundation for Innovation, Ontario Ministry of Research and Innovation, and more. These agencies fund only the most competitive research in Canada.